Clinical TrialsSearch results
Number of results: 2471
Recruiting
- A Randomized, Controlled, Multiregional Phase 3 Study of Ivonescimab Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (HARMONi-3)
- Squamous Non-small Cell Lung Cancer
- Noam Frey
- 2024-03-11
Recruiting
- Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
- Atypical Hemolytic Uremic Syndrome
- Iwasaki Ryohei
- 2024-03-11
Recruiting
- Perioperative chemotherapy and surgery vs. upfront surgery followed by adjuvant chemotherapy for patients with initial resectable colorectal liver metastases: A multi-center randomized controlled trial
- colorectal cancer liver metastases
- Hasegawa Kiyoshi
- 2024-03-07
Not yet recruiting
- 24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up
- Chronic Spontaneous Urticaria
- Iwasaki Ryohei
- 2024-03-06
Recruiting
- Investigation of the Effect of Air Purifiers with TPA Filters on Allergy Symptoms
- cedar pollen allergy
- Yoshikawa Sumiyo
- 2024-03-06
Recruiting
- Pembrolizumab dose-optimization study
- Non-small cell lung cancer
- Kunito Hideo
- 2024-03-06
Recruiting
- A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.
- ER+/HER2- advanced or metastatic breast cancer
- Kawai Norisuke
- 2024-03-05
Recruiting
- FAITHFUL Study
- Rheumatoid arthritis
- Kaneko Yuko
- 2024-03-05
Recruiting
- Mepolizumab efficacy and pathogenesis studies in patients with early-onset EGPA.
- eosinophilic granulomatosis with polyangiitis, EGPA
- Taniguchi Masami
- 2024-03-05
Recruiting
- ONO-4538HSC-01:A phase I study of ONO-4538HSC in subjects with advanced or metastatic solid tumors
- Advanced or metastatic solid tumors
- Hirashima Yoshinori
- 2024-03-05